IN8bio, Inc. 6JH.F Stock
IN8bio, Inc. Price Chart
IN8bio, Inc. 6JH.F Financial and Trading Overview
| IN8bio, Inc. stock price | 1.36 EUR |
| Previous Close | 1.95 EUR |
| Open | 1.9 EUR |
| Bid | 1.95 EUR x N/A |
| Ask | 2 EUR x N/A |
| Day's Range | 1.9 - 1.9 EUR |
| 52 Week Range | 0.94 - 2.94 EUR |
| Volume | 500 EUR |
| Avg. Volume | 93 EUR |
| Market Cap | 56.53M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.84 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6JH.F Valuation Measures
| Enterprise Value | 57.14M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.82318 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.947 |
Trading Information
IN8bio, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 11.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.94 EUR |
| 52 Week Low | 0.94 EUR |
| 50-Day Moving Average | 1.85 EUR |
| 200-Day Moving Average | 1.85 EUR |
6JH.F Share Statistics
| Avg. Volume (3 month) | 93 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 29.75M |
| Float | 14.88M |
| Short Ratio | N/A |
| % Held by Insiders | 25.27% |
| % Held by Institutions | 8.88% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -61.72% |
| Return on Equity (ttm) | -120.51% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -29357000 EUR |
| Net Income Avi to Common (ttm) | -29901000 EUR |
| Diluted EPS (ttm) | -1.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.86M EUR |
| Total Cash Per Share (mrq) | 0.37 EUR |
| Total Debt (mrq) | 5.53M EUR |
| Total Debt/Equity (mrq) | 32.93 EUR |
| Current Ratio (mrq) | 3.843 |
| Book Value Per Share (mrq) | 0.673 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -27001000 EUR |
| Levered Free Cash Flow (ttm) | -19202376 EUR |
Profile of IN8bio, Inc.
| Country | Germany |
| State | NY |
| City | New York |
| Address | 350 5th Avenue |
| ZIP | 10118 |
| Phone | 646 600 6438 |
| Website | https://in8bio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidates include INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation; and INB-400, which is in Phase 2 clinical trial to treat newly diagnosed GBM. It also develops INB-300, INB-410, and INB-500 that are in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Q&A For IN8bio, Inc. Stock
What is a current 6JH.F stock price?
IN8bio, Inc. 6JH.F stock price today per share is 1.36 EUR.
How to purchase IN8bio, Inc. stock?
You can buy 6JH.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IN8bio, Inc.?
The stock symbol or ticker of IN8bio, Inc. is 6JH.F.
Which industry does the IN8bio, Inc. company belong to?
The IN8bio, Inc. industry is Biotechnology.
How many shares does IN8bio, Inc. have in circulation?
The max supply of IN8bio, Inc. shares is 44.12M.
What is IN8bio, Inc. Price to Earnings Ratio (PE Ratio)?
IN8bio, Inc. PE Ratio is now.
What was IN8bio, Inc. earnings per share over the trailing 12 months (TTM)?
IN8bio, Inc. EPS is -0.84 EUR over the trailing 12 months.
Which sector does the IN8bio, Inc. company belong to?
The IN8bio, Inc. sector is Healthcare.